Show notes at pharmacyjoe.com/episode1058. In this episode, I’ll discuss recent guidelines about fluid removal in critically ill patients. The post…

Reduced-dose apixaban maintains efficacy with less bleeding for extended CAT prophylaxis, reinforcing NCCN’s pre-existing guidance in intermediate to high-risk cancer…

Research reveals associations between body composition, fitness, and mental health in children, highlighting the impact of obesity on anxiety and…

New research reveals that women on beta-blockers post-heart attack face a 45% higher risk of serious health issues compared with…

Women using depot medroxyprogesterone acetate face a significantly higher risk of meningioma, especially with long-term use or starting after age…

By targeting 2 chromatin complexes that jointly sustain ER‑driven transcription, this combination achieves superior suppression of tumor growth and gene…

Sherry Vogt, PharmD, BCOP; and Megan Hinkley, PharmD, MBA, BCOP, discuss how pharmacists play a crucial role in managing patients…

David Eagle, MD, Chair of Legislative Affairs and Patient Advocacy, explains how CMS’s ban on community oncology practices mailing medications…

Compared with rivaroxaban, abelacimab significantly lowered bleeding risk in patients (AF) regardless of kidney function.

Abemaciclib significantly enhances overall survival in high-risk HR+, HER2- early breast cancer, establishing a new standard of care.